WAFIK ZAKY to Child
This is a "connection" page, showing publications WAFIK ZAKY has written about Child.
Connection Strength
0.381
-
Ganglioglioma in children and young adults: single institution experience and review of the literature. J Neurooncol. 2018 Sep; 139(3):739-747.
Score: 0.035
-
Pediatric choroid plexus carcinoma: Biologically and clinically in need of new perspectives. Pediatr Blood Cancer. 2018 07; 65(7):e27031.
Score: 0.034
-
The ubiquitin-proteasome pathway in adult and pediatric brain tumors: biological insights and therapeutic opportunities. Cancer Metastasis Rev. 2017 12; 36(4):617-633.
Score: 0.033
-
Primary intracranial soft tissue sarcomas in children, adolescents, and young adults: single institution experience and review of the literature. J Neurooncol. 2016 Mar; 127(1):155-63.
Score: 0.029
-
The biologic era of childhood medulloblastoma and clues to novel therapies. Future Oncol. 2014 Mar; 10(4):637-45.
Score: 0.026
-
Treatment of children with diffuse intrinsic pontine gliomas with chemoradiotherapy followed by a combination of temozolomide, irinotecan, and bevacizumab. Pediatr Hematol Oncol. 2013 Oct; 30(7):623-32.
Score: 0.025
-
Safety and pharmacokinetics of ONC201 (dordaviprone) administered two consecutive days per week in pediatric patients with H3 K27M-mutant glioma. Neuro Oncol. 2024 May 03; 26(Supplement_2):S155-S164.
Score: 0.013
-
Everolimus in combination with vandetanib in children, adolescents, and young adults: a phase I study. ESMO Open. 2023 Dec; 8(6):101609.
Score: 0.013
-
Prognostic factors for pediatric, adolescent, and young adult patients with non-DIPG grade 4 gliomas: a contemporary pooled institutional experience. J Neurooncol. 2023 Jul; 163(3):717-726.
Score: 0.012
-
Retrospective Analysis of Imaging Characteristics of Tectal Gliomas. J Comput Assist Tomogr. 2023 Jan-Feb 01; 47(1):136-143.
Score: 0.012
-
Pediatric Central Nervous System Cancers, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2022 12; 20(12):1339-1362.
Score: 0.012
-
Contrast Enhancement Patterns in Pediatric Glioblastomas. J Comput Assist Tomogr. 2023 Jan-Feb 01; 47(1):115-120.
Score: 0.012
-
Quantifying the risk and dosimetric variables of symptomatic brainstem injury after proton beam radiation in pediatric brain tumors. Neuro Oncol. 2022 09 01; 24(9):1571-1581.
Score: 0.012
-
Patterns of care for pediatric patients with newly-diagnosed grade II gliomas. Childs Nerv Syst. 2021 05; 37(5):1563-1572.
Score: 0.010
-
Pharmacologic inhibition of lysine-specific demethylase 1 as a therapeutic and immune-sensitization strategy in pediatric high-grade glioma. Neuro Oncol. 2020 09 29; 22(9):1302-1314.
Score: 0.010
-
Posttreatment Maturation of Medulloblastoma into Gangliocytoma: Report of 2 Cases. Pediatr Neurosurg. 2020; 55(4):222-231.
Score: 0.010
-
Dual inhibition of BRAF and mTOR in BRAFV600E -mutant pediatric, adolescent, and young adult brain tumors. Cold Spring Harb Mol Case Stud. 2020 08; 6(4).
Score: 0.010
-
Phase I study of intraventricular infusions of autologous ex vivo expanded NK cells in children with recurrent medulloblastoma and ependymoma. Neuro Oncol. 2020 08 17; 22(8):1214-1225.
Score: 0.010
-
Pediatric high-grade glioma: aberrant epigenetics and kinase signaling define emerging therapeutic opportunities. J Neurooncol. 2020 Oct; 150(1):17-26.
Score: 0.010
-
Pediatric and adult H3 K27M-mutant diffuse midline glioma treated with the selective DRD2 antagonist ONC201. J Neurooncol. 2019 Oct; 145(1):97-105.
Score: 0.009
-
Phase-contrast cerebrospinal fluid flow magnetic resonance imaging in qualitative evaluation of patency of CSF flow pathways prior to infusion of chemotherapeutic and other agents into the fourth ventricle. Childs Nerv Syst. 2018 03; 34(3):481-486.
Score: 0.008
-
Extending the Neuroanatomic Territory of Diffuse Midline Glioma, K27M Mutant: Pineal Region Origin. Pediatr Neurosurg. 2018; 53(1):59-63.
Score: 0.008
-
Radiotherapy after high-dose chemotherapy with autologous hematopoietic cell rescue: Quality assessment of Head Start III. Pediatr Blood Cancer. 2017 Oct; 64(10).
Score: 0.008
-
Methotrexate administration directly into the fourth ventricle in children with malignant fourth ventricular brain tumors: a pilot clinical trial. J Neurooncol. 2015 Oct; 125(1):133-41.
Score: 0.007
-
Ikaros deletions in BCR-ABL-negative childhood acute lymphoblastic leukemia are associated with a distinct gene expression signature but do not result in intrinsic chemoresistance. Pediatr Blood Cancer. 2014 Oct; 61(10):1779-85.
Score: 0.007
-
Preliminary experience with diffusion tensor imaging before and after re-irradiation treatments in children with progressive diffuse pontine glioma. Childs Nerv Syst. 2014 May; 30(5):925-30.
Score: 0.006